Intraperitoneal Bupivacaine Does Not Attenuate Pain Following Laparoscopic Cholecystectomy by Zmora, Oded et al.
Intraperitoneal Bupivacaine Does Not Attenuate Pain
Following Laparoscopic Cholecystectomy
JSLS(2000)4:301-304 301
ABSTRACT
Background: Laparoscopic cholecystectomy is charac-
terized by a short hospital stay.  Hence, pain control on
the day of surgery is increasingly important.  The aim of
this study was to evaluate the effect of intraperitoneal
bupivacaine on pain relief following laparoscopic chole-
cystectomy.
Methods: Sixty patients undergoing elective laparo-
scopic cholecystectomy were prospectively randomized
into 2 groups.  Following removal of the gallbladder,
group A received 100 mg of bupivacaine in 50 cc of
saline, installed into the gallbladder bed and right sub-
phrenic space.  Group B received saline without bupiva-
caine.  Pain was assessed using a visual/analog scale at
fixed-time intervals. 
Results: No significant difference occurred in the aver-
age pain levels between the groups at 1, 2, 4, and 14
hours postsurgery.  The average analgesic requirement
was lower in the bupivacaine group, but this did not
reach statistical significance.
Conclusion: Application of intraperitoneal bupivacaine
did not attenuate pain following laparoscopic cholecys-
tectomy, and no role exists for its routine use.
Key Words: Laparoscopy, Cholecystectomy, Postoperative
pain, Bupivacaine
INTRODUCTION
The introduction of laparoscopic techniques into general
surgery has dramatically changed our attitudes about the
postoperative course of patients after cholecystectomy.
Laparoscopic cholecystectomy is characterized by a short
hospital stay and an early return to normal activity.
Typically, patients are discharged home on the first post-
operative day.  As experience has expanded, a few
recently reported series have shown that this operation is
safe and feasible as an outpatient procedure in properly
selected patients.1-3 Thus, pain relief and patient comfort
on the day of surgery have become increasingly impor-
tant, as the need for analgesics may delay discharge on
the same day.
Pain on the day of surgery is typically a diffuse abdomi-
nal pain, more so to the right upper quadrant, and radi-
ates to the right shoulder.4 We assumed that this pain is
mainly generated by irritation of the peritoneum, espe-
cially at the right upper abdomen, and hypothesized that
the application of a local anesthetic agent into the peri-
toneal cavity would reduce this pain.
The aim of this study was to evaluate the use of intraperi-
toneal bupivacaine on pain relief following laparoscopic
cholecystectomy.
MATERIALS AND METHODS
Sixty patients undergoing elective laparoscopic cholecys-
tectomy were prospectively randomized into 2 groups.
Group A received 100 mg of bupivacaine diluted in 50
mL of saline and installed into the peritoneal cavity.
Group B received intraperitoneal saline.  Following
removal of the gallbladder and thorough irrigation, a
feeding tube was inserted through the 5 mm trocar at the
right upper quadrant, and its tip was guided using a
grasping instrument inserted through the subxyphoid
port.  The solution was then released into the gallblad-
der bed and right subphrenic space, and the gas and
instruments were removed.
Pain was assessed using a visual/analog scale of 1 to 10,
at 1, 2, 4 and 14 hours after the end of the operation.  All
the patients were allowed to receive analgesic medica-
tions as needed, and the requirement of these medica-
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tions was recorded.  Analgesic medications included 1
mg per Kg of intramuscular meperidine on the day of sur-
gery, and 5 mg of oral oxycodone with 325 mg of aceta-
minophen on the following day, except in cases of aller-
gy to these drugs.
The patients, the surgeons, and the nursing staff were
blinded to the randomization.  Anesthesia was adminis-
tered according to a uniform study protocol to minimize
the effect of different anesthesia drugs and techniques on
the study results.
The study was approved by the local investigational
review board for clinical studies, and all the patients gave
their informed consent.
Patients in whom the procedure was converted to an
open procedure and patients in whom a drain was left in
the peritoneal cavity were excluded from the study.
Statistical analysis was performed using a two-tailed t test
and chi-square analysis, and significance was determined
as p<0.05.
RESULTS
Nine patients were excluded from the study for the rea-
sons mentioned above, leaving 51 patients for the data
analysis.  Twenty-six of them received bupivacaine, and
25 received saline.  Mean age and sex distribution did not
differ significantly between the two groups (Table 1).
No significant difference occurred in the average pain
levels between patients who received intraperitoneal
bupivacaine and patients who received saline at all the
time intervals (Figure 1).  Furthermore, the difference
between the average pain scores of the two groups was
less than one at all time intervals, suggesting that this dif-
ference is not clinically significant.
The average analgesic requirement was lower in the
bupivacaine group, but this did not reach statistical sig-
nificance (Figure 2).
DISCUSSION
Although minimally invasive surgery is characterized by
reduced pain, it is not painless.5 Patients undergoing
laparoscopic cholecystectomy suffer considerable pain on
the day of surgery, frequently requiring narcotic anal-
gesics.  The average pain scores of the entire group in
our series was 5.5 in a scale of 1 to 10 in 1 hour, 4.25 in
2 hours, and 3.3 in 4 hours postsurgery.
Table 1.
Demographic data of the study groups.
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Figure 1. Average pain levels, on a visual/analog scale of 1 to
10, at fixed time intervals from completion of the surgical proce-
dure.
Figure 2. Average number of doses of analgetic medications per
patient in each group. Each analgetic dose consisted of 1 mg/kg
of meperidine (except in cases of meperidine allergy).The pain characteristics suggest an intra-abdominal ori-
gin, and it seems unlikely that this pain is generated
mainly by the small skin incisions.  Studies of local anes-
thetics infiltrated into the skin wounds report reduced
postoperative pain only to a minor degree.6,7 Pain may
be generated by stretching of the abdominal wall during
the pneumoperitoneum, by the local dissection, or by
irritation of the peritoneum from blood, bile spillage, or
by the CO2 used for creation of the pneumoperitoneum. 
We  assumed that early postoperative pain was mainly
generated by irritation of the peritoneum, and the appli-
cation of a local anesthetic agent may attenuate this pain.
Previous studies have suggested that the use of local
anesthetics to block the afferent pain sensation may
reduce the central hyper-excitability of the dorsal horn
neurons in the spinal cord, in response to surgical trau-
ma.8 Clinical studies of intraperitoneal bupivacaine have
had inconsistent results.  Whereas few authors have
found a statistically significant difference with the use of
local anesthetics,8-13 others, including those of this study,
could not repeat these results.4,14-17 Furthermore, in a
few of the studies that have found a statistically signifi-
cant difference with the use of bupivacaine, the differ-
ence between the average pain scores was less than 1 in
a scale of 1 to 10.9,12 Although this difference was found
to be significant in statistical tests, it is doubtful whether
such a difference is of clinical significance.
This study suggests that intraperitoneal bupivacaine
installed at the end of the procedure did not attenuate
pain following laparoscopic cholecystectomy.
Pasqualucci et al18 and Mraovic et al10 have suggested
that application of local anesthetics prior to the dissec-
tion of the gallbladder may enhance the effect and
reduce pain.  The sensory nerves conducting pain sen-
sation to the posterior horn of the spinal cord transmit
impulses during the dissection and may turn into a
hyper-excitable state.18 Thus, application of the local
anesthetic after the dissection is completed may not sig-
nificantly attenuate the excitability of these nerves.
Blocking these nerves prior to the dissection may result
in more successful attenuation of pain following laparo-
scopic cholecystectomy. 
The cause of the early postoperative pain in laparoscop-
ic cholecystectomy is not clearly understood.  The CO2
used to create the pneumoperitoneum may induce local
changes that irritate the peritoneum, such as local acido-
sis due to CO2 dissolution in the peritoneal tissue.
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Because the gas is equally distributed in the peritoneal
cavity, application of a local anesthetic agent to the right
upper quadrant may not be sufficient to attenuate this
pain.  Use of a higher volume of local anesthetic solu-
tion, sufficient to irrigate most of the peritoneal cavity,
may also improve the effect on pain after laparoscopy.
However, because absorption of the drug from the peri-
toneum occurs, care should be taken not to administer
overdoses of these agents.
CONCLUSION
Intraperitoneal bupivacaine did not attenuate pain fol-
lowing laparoscopic cholecystectomy in this study. These
results suggest that no role exists for the use of intraperi-
toneal bupivacaine, in the fashion described here, in
laparoscopic cholecystectomy.  Further studies are need-
ed to establish the role of intraperitoneal bupivacaine for
pain relief in laparoscopic surgery.
References:
1. Mjaland O, Reader J, Aesboe V, Trondsen E, Buanes T.
Outpatient laparoscopic cholecystectomy.  Br J Surg.
1997;84:958-961.
2. Keulmans Y, Eshuis J, de Haes H, de Wit LT, Gouma DJ.
Laparoscopic cholecystectomy:  day-care versus clinical observa-
tion.  Ann Surg.  1998;228:734-740.
3. Simpson JP, Savarise MT, Moore J.  Outpatients laparoscop-
ic cholecystectomy:  What predicts the need for admission?  Am
Surg. 1999;65:525-528.
4. Joris J, Thiry E, Paris P, Weerts J, Lamy M.  Pain after laparo-
scopic cholecystectomy: characteristics and effect of intraperi-
toneal bupivacaine.  Anesth Analg.  1995;81:379-384.
5. Stevens HP, van de Berg M, Ruseler CH, Wereldmasa JC.
Clinical and financial aspects of cholecystectomy:  laparoscopic
versus open technique.  World J Surg.  1997;21:91-96.
6. Kum CK, Wong CW, Goh PM, Ti TK.  Comparative study of
pain level and analgesic requirement after laparoscopic and
open cholecystectomy.  Surg Laparosc Endosc. 1994;4:139-141. 
7. Dath D, Park AK.  Randomized, controlled trial of bupiva-
caine injection to decrease pain after laparoscopic cholecystec-
tomy.  Can J Surg. 1999;42:284-288. 
8. Dahl JB, Erichsen CJ, Fuglsang-Frederikson A, Kehlet H.
Pain sensation and nociceptive reflex excitability in volunteers
and surgical patients.  Br J Anesth.  1992;69:117-121.
9. Szem JW, Hydo L, Barie PS.  A double blind evaluation of
intraperitoneal bupivacaine vs saline for the reduction of post-
operative pain and nausea after laparoscopic cholecystectomy.
Surg Endosc.  1996;10:44-48.Intraperitoneal Bupivacaine Does Not Attenuate Pain Following Laparoscopic Cholecystectomy, Zmora O et al.
304 JSLS(2000)4:301-304
10. Mraovic B, Jurisic T, Kogler-Majeric V, Sustic A.
Intraperitoneal bupivacaine for analgesia after laparoscopic
cholecystectomy.  Acta Anesthesiol Scand.  1997;41:193-196. 
11. Weber A, Munoz J, Garteiz D, Cueto J.  Use of subdiaphrag-
matic bupivacaine installed to control postoperative pain after
laparoscopic surgery.  Surg Laparosc Endosc.  1997;7:6-8.
12. Tsimoyiannis EC, Glatzounis G, Lekkas ET, Siakas P, Jabarin
M, Tzourou H.  Intraperitoneal normal saline and bupivacaine
infusion for reduction of postoperative pain after laparoscopic
cholecystectomy.  Surg Laparosc Endosc.  1998;8:416-420.
13. Cunniffe MG, McAnena OJ, Calleary J, Flynn N.  A prospec-
tive randomized trial of intraperitoneal bupivacaine irrigation for
management of shoulder-tip pain following laparoscopy.  Am J
Surg.  1998;176:258-261.
14. Schulte-Steinberg H, Weninger E, Jokisch D, et al.
Intraperitoneal versus intrapleural morphine or bupivacaine for
pain after laparoscopic cholecystectomy.  Anesthesiol.
1995;82:634-640.
15. Scheinin B, Kellokumpu I, Ligdgren L, Haglund C,
Rosenberg PH.  Effect of intraperitoneal bupivacaine on pain after
laparoscopic cholecystectomy.  Acta Anesthesiol Scand.
1995;39:195-198.
16. Raetzell M, Maier C, Schroder D, Wolf H.  Intraperitoneal
application of bupivacaine during laparoscopic cholecystectomy-
risk and benefit?  Anesth Analg. 1995;81:967-972.
17. Johnson RC, Hedges AR, Morris R, Stamatakis JD.  Ideal pain
relief following laparoscopic cholecystectomy.  Int J Clin Pract.
1999;53:16-18.
18. Pasqualucci A, De Angelis V, Contardo R, et al.  Preemptive
analgesia:  Intraperitoneal local anesthetic in laparoscopic chole-
cystectomy.  Anesthesiol.  1996;85:11-20.
Presented at the 8th International Meeting of Laparoendoscopic
Surgeons, SLS Annual Meeting Endo Expo ‘99,  December 4-7,
1999, in New York City, USA
Statement of Disclosure:  None of the authors have any financial
interest in any commercial drug, device, equipment, or instru-
ment that is the subject of this article.  This study was not sup-
ported by any commercial or drug company.